Nanologica AB (publ) (STO:NICA)
Sweden · Delayed Price · Currency is SEK 0.3590
-0.0070 (-1.91%)
Sep 2, 2026, 5:29 PM CET
Nanologica AB Market Cap
Nanologica AB has a market cap or net worth of 120.33 million as of September 2, 2026. Its market cap has increased by 2.00% in one year.
Market Cap
120.33M
Enterprise Value
154.90M
Revenue
136.17M
Ranking
n/a
PE Ratio
3.80
Stock Price
0.36
ChartMarket Cap Chart
Since October 30, 2015, Nanologica AB's market cap has increased from 73.54M to 120.33M, an increase of 63.62%. That is a compound annual growth rate of 4.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 118.03M | 71.23% |
| Dec 30, 2025 | 68.93M | -57.14% |
| Dec 30, 2024 | 160.81M | -57.22% |
| Dec 29, 2023 | 375.92M | 33.47% |
| Dec 30, 2022 | 281.66M | -27.01% |
| Dec 30, 2021 | 385.87M | 3.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 195.75M |
| Elicera Therapeutics AB | 190.20M |
| Alzinova AB | 170.22M |
| Abera Bioscience AB | 166.86M |
| Diamyd Medical AB | 160.25M |
| Initiator Pharma | 157.44M |
| Xintela AB | 145.98M |
| NextCell Pharma AB | 139.03M |